FIB-4 stage of liver fibrosis predicts incident heart failure among HIV-infected and uninfected patients.
Kaku A So-ArmahJoseph K LimVincent Lo ReJanet P TateChung-Chou H ChangAdeel A ButtCynthia L GibertDavid RimlandVincent C MarconiMatthew B GoetzMaria C Rodriguez-BarradasMatthew J BudoffHilary A TindleJeffrey H SametAmy C JusticeMatthew S Freibergnull nullPublished in: Hepatology (Baltimore, Md.) (2017)
Moderate and advanced liver fibrosis/cirrhosis are associated with an increased risk of CHF. The association for advanced fibrosis/cirrhosis persists even among participants without hepatitis C and/or HIV infection. Assessing liver health may be important for reducing the risk of future CHF events, particularly among HIV and hepatitis C infected people among whom cardiovascular disease risk is elevated and liver disease is common. (Hepatology 2017;66:1286-1295).
Keyphrases
- liver fibrosis
- hiv infected
- antiretroviral therapy
- cardiovascular disease
- heart failure
- human immunodeficiency virus
- end stage renal disease
- hiv positive
- hiv aids
- ejection fraction
- healthcare
- public health
- chronic kidney disease
- newly diagnosed
- mental health
- type diabetes
- peritoneal dialysis
- left ventricular
- current status
- coronary artery disease
- risk assessment
- patient reported outcomes
- south africa
- climate change
- health information
- cardiovascular events